Commercial scale up of CMV and EBV specific T-cell manufacturing

Read full text
Authors: Therapeutic Innovation Australia
Cited by: 0

Fields of Study & Subjects

Cytomegalovirus and herpesvirus research Immunotherapy and Immune Responses CAR-T cell therapy research

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
17 February 2026
Language
EN